4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-032065
Chief Operating Officer sold 2,642 shares at $1.25 ($3,300)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DiBiase Mary Chief Operating Officer | 2023-09-08 | Sale | −2,642 | $1.25 | $3,300 | 147,894 | D |
| Open-market sales · 2,642 sh · avg $1.25 · $3,300 | |||||||
Loading xslF345X05/wk-form4_1694549085.xml…